Ikarovec
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $9.8M
Investors
- 4
About Ikarovec
Founded in 2019 in England, UK, Ikarovec Limited specializes in gene therapy for ocular conditions. Ikarovec has two deals recorded, with the most recent deal occurring on October 8, 2024.Ikarovec specializes in innovative gene therapy solutions for the treatment of common eye diseases, operating in the pre-clinical phase of drug development. The company’s core product offerings focus on advanced gene therapy treatments that aim to restore sight and prevent blindness by targeting multiple disease pathways simultaneously. This is achieved through a technique known as gene transfer, which introduces therapeutic DNA into target cells in the eye, enabling them to produce specific proteins that combat various ocular conditions. Ikarovec's research programs are primarily aimed at age-related macular degeneration (AMD) and geographic atrophy (GA), among other conditions.Ikarovec's revenue model is structured around strategic partnerships and collaborations with biopharmaceutical companies, allowing for shared resources and expertise in advancing their gene therapy programs. Transactions are primarily B2B, with financial arrangements likely involving milestone payments tied to development progress and potential royalties upon commercialization of the therapies. Revenue generation will be closely linked to the progression of their gene therapy treatments through various stages of development, with a focus on securing partnerships for distribution and commercialization in targeted markets. This therapy aims to deliver two clinically significant proteins with a single injection, targeting inflammation and oxidative stress associated with geographic atrophy (GA).
Who invested in Ikarovec
4 investors across 2 rounds
See all investors in Ikarovec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ikarovec
Who invested in Ikarovec?
Ikarovec has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ikarovec raised?
Ikarovec has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ikarovec last raise money?
Ikarovec's most recent round on record is a Seed, in Oct 2024.
What does Ikarovec do?
Founded in 2019 in England, UK, Ikarovec Limited specializes in gene therapy for ocular conditions.
Where is Ikarovec headquartered?
Ikarovec is headquartered in Norwich, UK.
Which VCs invest in companies like Ikarovec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Ikarovec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ikarovec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.